VC-backed NeuroPace goes public
Silicon Valley-based medical device company NeuroPace has raised $102 million for its IPO after pricing its 6 million shares at $17 per share.
Silicon Valley-based medical device company NeuroPace has raised $102 million for its IPO after pricing its 6 million shares at $17 per share.
Copyright PEI Media
Not for publication, email or dissemination